These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 32929346

  • 1. Histone deacetylase inhibitors promote epithelial-mesenchymal transition in Hepatocellular Carcinoma via AMPK-FOXO1-ULK1 signaling axis-mediated autophagy.
    Xiao Q, Liu H, Wang HS, Cao MT, Meng XJ, Xiang YL, Zhang YQ, Shu F, Zhang QG, Shan H, Jiang GM.
    Theranostics; 2020; 10(22):10245-10261. PubMed ID: 32929346
    [Abstract] [Full Text] [Related]

  • 2. Histone deacetylase inhibitors upregulate Snail via Smad2/3 phosphorylation and stabilization of Snail to promote metastasis of hepatoma cells.
    Xu W, Liu H, Liu ZG, Wang HS, Zhang F, Wang H, Zhang J, Chen JJ, Huang HJ, Tan Y, Cao MT, Du J, Zhang QG, Jiang GM.
    Cancer Lett; 2018 Apr 28; 420():1-13. PubMed ID: 29410023
    [Abstract] [Full Text] [Related]

  • 3. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T, Zhang Y, Chen Y, Liu P, An T, Zhang J, Yang H, Zhu W, Yang X.
    Oncotarget; 2017 Jan 03; 8(1):1703-1713. PubMed ID: 27924058
    [Abstract] [Full Text] [Related]

  • 4. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L, Chang Y, Cao P.
    Exp Cell Res; 2018 Oct 01; 371(1):231-237. PubMed ID: 30107147
    [Abstract] [Full Text] [Related]

  • 5. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
    Kwon HY, Kim JH, Kim B, Srivastava SK, Kim SH.
    Arch Toxicol; 2018 Jan 01; 92(1):241-257. PubMed ID: 28676953
    [Abstract] [Full Text] [Related]

  • 6. Platelets promote primary hepatocellular carcinoma metastasis through TGF-β1-mediated cancer cell autophagy.
    Lu M, Gong X, Zhang YM, Guo YW, Zhu Y, Zeng XB, Gao JH, Liu LM, Shu D, Ma R, Liang HF, Zhang RY, Xu Y, Zhang BX, Lu YJ, Ming ZY.
    Cancer Lett; 2024 Sep 28; 600():217161. PubMed ID: 39117067
    [Abstract] [Full Text] [Related]

  • 7. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target.
    Qin CD, Ma DN, Zhang SZ, Zhang N, Ren ZG, Zhu XD, Jia QA, Chai ZT, Wang CH, Sun HC, Tang ZY.
    Cell Death Dis; 2018 May 01; 9(5):486. PubMed ID: 29706627
    [Abstract] [Full Text] [Related]

  • 8. ZnAs@SiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling.
    Huang Y, Zhou B, Luo H, Mao J, Huang Y, Zhang K, Mei C, Yan Y, Jin H, Gao J, Su Z, Pang P, Li D, Shan H.
    Theranostics; 2019 May 01; 9(15):4391-4408. PubMed ID: 31285768
    [Abstract] [Full Text] [Related]

  • 9. Plumbagin promotes human hepatoma SMMC-7721 cell apoptosis via caspase-3/vimentin signal-mediated EMT.
    Wei Y, Lv B, Xie J, Zhang Y, Lin Y, Wang S, Zhong J, Chen Y, Peng Y, Ma J.
    Drug Des Devel Ther; 2019 May 01; 13():2343-2355. PubMed ID: 31409969
    [Abstract] [Full Text] [Related]

  • 10. I131 reinforces antitumor activity of metuximab by reversing epithelial-mesenchymal transition via VEGFR-2 signaling in hepatocellular carcinoma.
    Wu L, Sun B, Lin X, Liu C, Qian H, Chen L, Yang Y, Shen F, Su C.
    Genes Cells; 2018 Jan 01; 23(1):35-45. PubMed ID: 29210217
    [Abstract] [Full Text] [Related]

  • 11. Simvastatin-induced cell cycle arrest through inhibition of STAT3/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells.
    Wang ST, Ho HJ, Lin JT, Shieh JJ, Wu CY.
    Cell Death Dis; 2017 Feb 23; 8(2):e2626. PubMed ID: 28230855
    [Abstract] [Full Text] [Related]

  • 12. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
    Chi HC, Chen SL, Cheng YH, Lin TK, Tsai CY, Tsai MM, Lin YH, Huang YH, Lin KH.
    Cell Death Dis; 2016 Aug 04; 7(8):e2324. PubMed ID: 27490929
    [Abstract] [Full Text] [Related]

  • 13. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
    Huang X, Gan G, Wang X, Xu T, Xie W.
    Autophagy; 2019 Jul 04; 15(7):1258-1279. PubMed ID: 30786811
    [Abstract] [Full Text] [Related]

  • 14. Sanguinarine inhibits epithelial-mesenchymal transition via targeting HIF-1α/TGF-β feed-forward loop in hepatocellular carcinoma.
    Su Q, Fan M, Wang J, Ullah A, Ghauri MA, Dai B, Zhan Y, Zhang D, Zhang Y.
    Cell Death Dis; 2019 Dec 09; 10(12):939. PubMed ID: 31819036
    [Abstract] [Full Text] [Related]

  • 15. Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP, Zhao XC.
    Exp Biol Med (Maywood); 2018 Apr 09; 243(7):645-654. PubMed ID: 29486578
    [Abstract] [Full Text] [Related]

  • 16. Histone deacetylase inhibitor trichostatin A and autophagy inhibitor chloroquine synergistically exert anti-tumor activity in H-ras transformed breast epithelial cells.
    Gao L, Sun X, Zhang Q, Chen X, Zhao T, Lu L, Zhang J, Hong Y.
    Mol Med Rep; 2018 Mar 09; 17(3):4345-4350. PubMed ID: 29344672
    [Abstract] [Full Text] [Related]

  • 17. Mannose-mediated inhibitory effects of PA-MSHA on invasion and metastasis of hepatocellular carcinoma via EGFR/Akt/IκBβ/NF-κB pathway.
    Li T, Dong ZR, Guo ZY, Wang CH, Zhi XT, Zhou JW, Li DK, Chen ZT, Chen ZQ, Hu SY.
    Liver Int; 2015 Apr 09; 35(4):1416-29. PubMed ID: 25066210
    [Abstract] [Full Text] [Related]

  • 18. Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma.
    Yao J, Tang S, Shi C, Lin Y, Ge L, Chen Q, Ou B, Liu D, Miao Y, Xie Q, Tang X, Fei J, Yang G, Tian J, Zeng X.
    Autophagy; 2023 Apr 09; 19(4):1221-1238. PubMed ID: 36048765
    [Abstract] [Full Text] [Related]

  • 19. LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway.
    Song X, Wang J, Zheng T, Song R, Liang Y, Bhatta N, Yin D, Pan S, Liu J, Jiang H, Liu L.
    Mol Cancer; 2013 Oct 05; 12(1):114. PubMed ID: 24093956
    [Abstract] [Full Text] [Related]

  • 20. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
    Yin W, Xu J, Li C, Dai X, Wu T, Wen J.
    Cell Biol Int; 2020 Aug 05; 44(8):1616-1627. PubMed ID: 32239594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.